These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 3094965

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro testing of the antibacterial activity of fosfomycin trometamol against urinary pathogens.
    Rossi L, Fontana R, Meloni GA.
    Chemioterapia; 1988 Feb; 7(1):10-4. PubMed ID: 3259908
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of pH, inoculum and media on the in vitro bactericidal activity of fosfomycin trometamol, norfloxacin and cotrimoxazole.
    Albini E, Belluco G, Marca G.
    Chemioterapia; 1986 Aug; 5(4):268-72. PubMed ID: 3533286
    [Abstract] [Full Text] [Related]

  • 6. [Experimental cystitis in the rat and the therapeutic effect of a single dose of fosfomycin trometamol].
    Dubini F, Riviera L, Visconti A.
    Ann Ist Super Sanita; 1987 Aug; 23(4):803-7. PubMed ID: 3330644
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of lower urinary tract infections in children: single dose fosfomycin trometamol versus pipemidic acid.
    Careddu P, Borzani M, Scotti L, Varotto F, Garlaschi L, Fontana P.
    Chemioterapia; 1987 Aug; 6(4):290-4. PubMed ID: 3652281
    [Abstract] [Full Text] [Related]

  • 10. [Evolution from 1976 to 1986 of bacterial prevalence and sensitivity to urinary antibiotics of bacteria isolated from urine cultures at a city microbiology laboratory].
    Chouteau J.
    Pathol Biol (Paris); 1988 May; 36(5):439-41. PubMed ID: 3136425
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis.
    Gupta K, Hooton TM, Stamm WE.
    J Antimicrob Chemother; 2005 Jul; 56(1):243-6. PubMed ID: 15911548
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
    Ko KS, Suh JY, Peck KR, Lee MY, Oh WS, Kwon KT, Jung DS, Lee NY, Song JH.
    Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
    [Abstract] [Full Text] [Related]

  • 15. Fosfomycin for urinary tract infections.
    Med Lett Drugs Ther; 1997 Jul 18; 39(1005):66-8. PubMed ID: 9255237
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Our experience in the use of fosfomycin in human therapy].
    De Rosa F, Pauselli A, Matocci G, Petrucci G.
    Minerva Med; 1978 Dec 01; 69(59):4115-8. PubMed ID: 105328
    [No Abstract] [Full Text] [Related]

  • 18. In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim-nitrofuratoin combination.
    Patil P, Sharma V, Joshi BN.
    J Postgrad Med; 1979 Jul 01; 25(3):162-5. PubMed ID: 119047
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.